三辨治癌合并介入治疗中晚期胃癌43例  

43 Cases of Advanced Gastric Cancer Treated by Cancer Treatment Based on SPL Theory with Interventional Therapy

作　　者：方玉红[1] 李雪松[2] 袁素[1] 毕朝霞[1] 

机构地区：[1]石家庄华光中医肿瘤医院,河北石家庄050011 [2]石家庄市中医院,河北石家庄050000

出　　处：《辽宁中医杂志》2015年第3期535-536,共2页Liaoning Journal of Traditional Chinese Medicine

基　　金：河北省中医药管理局2013度中医药类科研计划课题(2013234)

摘　　要：目的:观察三辨治癌指导下参藤消胃积汤配合介入治疗中晚期胃癌的临床疗效。方法:口服参藤消胃积汤,每日1剂;同时配合介入,治疗中晚期胃癌。结果:CR+PR+NC=95.3%,中位生存期23个月,;1年生存率76.7%,2年生存率44.1%,3年生存率27.8%,4年生存率16.3%,5年生存率7.0%。结论:根据"三辨论治"即辨证论治、辨病理论治、辨病位论治,参藤消胃积汤配合介入治疗胃癌,能显著提高患者的生存质量及生存期,疗效显著。Objective： To evaluate the clinical therapeutic effect of henteng Xiaoweiji Decoction with the interventional therapy on advanced gastric cancer under the guidance of cancer treatment based on SPL theory. Methods： Oral Shen Teng Xiaoji medicinal broth,a dose of medicine everyday,it cures advanced gastric cancer cooperating interventional therapy. Results： The effective rate of tumor changes was 95. 3% and the effective rate of quality of life was 97. 7%. MST was 23 months and one-year survival rate was 76. 7%,two-year survival rate 44. 1%,three-year survival rate 27. 8%,four-year survival rate 16. 3%,five-year survival rate 7. 0%. Conclusion： According to the cancer treatment based on SPL theory,which contains differentiation of symptoms and signs,differentiation of pathological changes and differentiation of disease locations,Shenteng Xiaoweiji Decoction with interventional therapy can significantly improve the survival quality of the advanced gastric cancer patients and extend their life span.

关 键 词：三辨治癌 参藤消胃积汤 介入 中晚期胃癌 

分 类 号：R735.2[医药卫生—肿瘤]